The biggest USP for many insurers
14-05-2021
More on this story
08-03-2021
Claims departments are now key to re/insurers’ offerings, and technology is a big part of that. Liberty Specialty Markets’ Irene Stavrou discusses the company’s investments and why claims are about much more than simply paying out.
As another Re/insurance Lounge panel titled “How the use of tech and service can set insurers apart” discussed, insurers’ claims departments have seen a transformation over the last two decades and there’s no sign of it slowing down. Investments in technology have made notification and payments smoother and simpler and led to a whole range of broader services.
Katherine J Wu, The New York Times
Published: 07 Jan 2021 12:00 PM BdST
Updated: 07 Jan 2021 12:00 PM BdST A patient recovered from COVID-19 donated plasma at the Hemotherapy Institute in La Plata, Argentina, in October. Agustin Marcarian/Reuters
A small but rigorous clinical trial in Argentina has found that blood plasma from recovered COVID-19 patients can keep older adults from getting seriously sick with the coronavirus if they get the therapy within days of the onset of the illness. );
}
The results, published Wednesday in the New England Journal of Medicine, are some of the first to conclusively point toward the oft-discussed treatment’s beneficial effects. They arrive nearly five months after the Food and Drug Administration, under pressure from President Donald Trump, issued the therapy an emergency green light for use in people hospitalised with COVID-19.